First Page | Document Content | |
---|---|---|
Date: 2012-05-01 11:12:36Cancer treatments Adjuvant therapy Dysplastic nevus syndrome Sentinel lymph node Dacarbazine DecisionDx-UM Medicine Oncology Melanoma | ASCO Classic Oncology References Melanoma Epidemiology/Biology 1. Barnhill RL, Katzen J, Spatz A, et al The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma. J Cutan Pathol; 2005 Apr; 32Add to Reading ListSource URL: university.asco.orgDownload Document from Source WebsiteFile Size: 227,85 KBShare Document on Facebook |
Microsoft WordDabrafenib GSK PSD March 13 final...docxDocID: 12uHM - View Document | |
Microsoft WordVemurafenib Roche PSD MArch 2013 FINAL.docDocID: 12mhw - View Document | |
Sensitization to the mitochondrial pathway of apoptosis augments melanoma tumor cell responses to conventional chemotherapeutic regimensDocID: ZKrT - View Document | |
Kill or Cure Chemotherapy Answers: 1. Combination chemotherapy regime: Adriamycin (or doxorubicin), Vinblastine, Bleomycin, Dacarbazine. 2. Directly compared with the pre-therapy scan: previous disease in the right axillDocID: Yz0i - View Document | |
dabrafenib, 50mg and 75mg hard capsules (TafinlarĀ®) GlaxoSmithKline SMC No. (No[removed]February 2015DocID: WZc4 - View Document |